Real-World Use of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) in Adults With Recurrent Clostridioides difficile Infection in the United States

被引：0

作者：

Akerman, Stuart ^{[1
]}

Gumaste, Ashish ^{[2
]}

Chen, Michael ^{[3
]}

Connor, Lisa ^{[4
]}

von Eynatten, Maximilian ^{[5
]}

De Vries, Jane

Nguyen, Dianne ^{[2
]}

机构：

[1] Digest Hlth Associates Texas, Plano, TX USA

[2] Nestle Hlth Sci, Bridgewater, NJ USA

[3] Nestle Hlth Sci, Dallas, TX USA

[4] Nestle Hlth Sci, Lavallette, NJ USA

[5] Nestle Hlth Sci, Lausanne, Switzerland

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期

关键词：

D O I：

10.14309/01.ajg.0001030496.61161.3c

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S282

引用

页码：S202 / S202

页数：1

共 27 条

[1] Practical use of fecal microbiota spores, live-brpk (formerly SER-109): an oral therapeutic for the prevention of recurrent Clostridioides difficile infection
Rosenberg, Jonathan
Ritter, Timothy
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023,
[2] Safety of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) in Participants With Recurrent Clostridioides difficile Infection and Comorbidities: Findings From an Integrated Analysis of Phase 3 Trials
Sims, Matthew
Berenson, Charles S.
Stevens, Robert
Nguyen, Dianne
Pullman, John R.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S200 - S201
[3] Safety and Efficacy of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) in Older Patients With Recurrent Clostridioides difficile Infection: Findings From an Integrated Analysis of Phase 3 Trials
Lashner, Bret
von Moltke, Lisa
De, Ananya
Pardi, Darrell S.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S22 - S22
[4] SAFETY AND EFFICACY OF FECAL MICROBIOTA SPORES, LIVE-BRPK (FORMERLY SER-109) IN OLDER PATIENTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: FINDINGS FROM AN INTEGRATED ANALYSIS OF PHASE 3 TRIALS
Lashner, Bret
von Moltke, Lisa
De, Ananya
Pardi, Darrell S.
GASTROENTEROLOGY, 2024, 166 (05) : S574 - S574
[5] EXPERIENCE AND OUTCOMES WITH FECAL MICROBIOTA SPORES, LIVE-BRPK IN PATIENTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
Voth, Elida
Tariq, Raseen
Pardi, Darrell S.
Khanna, Sahil
GASTROENTEROLOGY, 2024, 166 (05) : S577 - S577
[6] Fecal microbiota spores, live-brpk (VOWST™/VOS) for prevention of recurrent Clostridioides difficile infection
Berry, Parul
Khanna, Sahil
FUTURE MICROBIOLOGY, 2024, 19 (18) : 1519 - 1528
[7] CLINICAL AND ECONOMIC OUTCOMES OF MICROBIOME THERAPY FOR PREVENTING RECURRENCE IN RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) IN THE US: COMPARISON OF FECAL MICROBIOTA SPORES, LIVE-BRPK (FORMERLY SER-109) VS FECAL MICROBIOTA, LIVE-JS']JSLM
Golan, Yoav
Amin, Alpesh
Wilson, Michele
Nguyen, Dianne
Kvasz, Marion
GASTROENTEROLOGY, 2024, 166 (05) : S575 - S575
[8] Practical Use of Fecal Microbiota Spores, Live BRPK for the Prevention of Recurrent Clostridioides difficile Infection
Allegretti, Jessica R.
Khanna, Sahil
Feuerstadt, Paul
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12): : 2106 - 2108
[9] Efficacy and Practical Implementation of Fecal Microbiota Spores, Live-BRPK: A Novel Approach for Preventing Recurrent Clostridioides difficile Infection
Feuerstadt, Paul
LaPlante, Kerry L.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (1S): : S22 - S26
[10] STEPS: New Drug Reviews Fecal Microbiota Spores, Live-Brpk (Vowst) to Prevent Clostridioides difficile Infection
Smith, Andrew
Roy, Tuhin
AMERICAN FAMILY PHYSICIAN, 2024, 109 (05) : 472 - 473

← 1 2 3 →